The Arteriovenous Vascular (AV) ACCESS Trial
Running, not enrolling · Not applicable
Conditions studied: End-Stage Kidney Disease, Hemodialysis Complication
In brief
This study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions
Key facts
- Study ID
- NCT04646226
- Run by
- Wake Forest University Health Sciences
- People needed
- 103
- Starts
- 2022-08-18
- Expected to finish
- 2027-08-31
- Last updated by the study team
- 2026-06-01
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 60 years or older
- End-stage kidney disease on hemodialysis via a central venous catheter
- Hemodialysis is the long-term modality of treatment for end-stage kidney disease
- Central venous catheter is the sole vascular access used for hemodialysis at the time of referral for arteriovenous access creation
- Referred by patient's nephrologist for placement of arteriovenous access
- At least one of the following comorbid conditions: cardiovascular disease, peripheral vascular disease, and/or diabetes mellitus
- Medically and surgically eligible to undergo surgical placement of an arteriovenous access, deemed by the treating healthcare providers
- Native vasculature deemed preoperatively to be suitable for surgical creation of either type of arteriovenous access (arteriovenous fistula or arteriovenous graft) in the opinion of the surgeon
- Patient agreed to study participation and signed the informed consent
You may not qualify if…
- Severe cardiac disease defined as presence of either of the following three conditions: congestive heart failure with ejection fraction ≤ 20%, heart transplant, or ventricular assist device
- Known or suspected central vein stenosis or vascular obstruction on the side of planned study access creation, unless corrected prior to randomization
- Planned arteriovenous fistula creation by means other than suture or vascular anastomotic clips (e.g. endovascular surgery or other anastomotic creation devices)
- Anticipated kidney transplant within 12 months
- Anticipated conversion to peritoneal dialysis within 12 months
- Anticipated transfer of nephrology care to a clinic outside the study participating centers within 12 months
- Anticipated non-compliance with medical care based on physician judgment
- A condition in which, in the opinion of the site PI renders the patient not a good candidate for study participation.
Where it is running
- University of Alabama at Birmingham School of Medicine — Birmingham, Alabama, United States
- UCLA — Los Angeles, California, United States
- Johns Hopkins School of Medicine — Baltimore, Maryland, United States
- Atrium Wake Forest Baptist Medical Center — Winston-Salem, North Carolina, United States
- Prisma Health Upstate — Greenville, South Carolina, United States
- University of Tennessee Medical Center at Knoxville — Knoxville, Tennessee, United States
- University of Wisconsin School of Medicine and Public Health — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.